European agency finds AstraZeneca can cause rare blood clots, but benefits outweigh risks

The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.

Click Here to read the entire article...